Gold Nanoparticles Supported on Ceria Nanoparticles Modulate Leukocyte–Endothelium Cell Interactions and Inflammation in Type 2 Diabetes

Abstract

Gold-ceria nanoparticles (Au/CeO2) are known to have antioxidant properties. However, whether these nanoparticles can provide benefits in type 2 diabetes mellitus (T2D) remains unknown. This work aimed to study the effects of Au/CeO2 nanoparticles at different rates of gold purity (10, 4.4, 1.79 and 0.82) on leukocyte–endothelium interactions and inflammation in T2D patients. Anthropometric and metabolic parameters, leukocyte–endothelium interactions, ROS production and NF-κB expression were assessed in 57 T2D patients and 51 healthy subjects. T2D patients displayed higher Body Mass Index (BMI) and characteristic alterations in carbohydrate and lipid metabolism. ROS production was increased in leukocytes of T2D patients and decreased by Au/CeO2 at 0.82% gold. Interestingly, Au/CeO2 0.82% modulated leukocyte–endothelium interactions (the first step in the atherosclerotic process) by increasing leukocyte rolling velocity and decreasing rolling flux and adhesion in T2D. A static adhesion assay also revealed diminished leukocyte–endothelium interactions by Au/CeO2 0.82% treatment. NF-κB (p65) levels increased in T2D patients and were reduced by Au/CeO2 treatment. Cell proliferation, viability, and apoptosis assays demonstrated no toxicity produced by Au/CeO2 nanoparticles. These results demonstrate that Au/CeO2 nanoparticles at 0.82% exert antioxidant and anti-inflammatory actions in the leukocyte–endothelium interaction of T2D patients, suggesting a protective role against the appearance of atherosclerosis and cardiovascular diseases when this condition exists.

Autophagy and mitophagy as potential therapeutic targets in diabetic heart condition: Harnessing the power of nanotheranostics

“…This suggests that if the patient is at a risk of developing any CVD, these nanoparticles will be protective in nature. These results correlated with the other cell viability assays carried out [ 166 ]. Coronary microcirculatory dysfunction (CMD) gives rise to DCM.…”

Emerging trends in nano-based antidiabetic therapeutics: a path to effective diabetes management

“…Various recent literature studies have explored NMs for inflammation modulation in DM, particularly emphasizing their anti-inflammatory effects and role in enhancing insulin sensitivity. 103,104…”

“…Furthermore, NMs can modulate pro-inflammatory signalling pathways, that include nuclear factor-kappa B (NF-kB) and mitogen-activated protein kinase (MAPK), leading to reduced production of inflammatory mediators and improved insulin sensitivity. Various recent literature studies have explored NMs for inflammation modulation in DM, particularly emphasizing their anti-inflammatory effects and role in enhancing insulin sensitivity 103,104.…”

Assessment of anti-inflammatory properties of metal nanoparticles as potential means for the correction of pathologies on the reproductive system in animals

“…Di Bella et al (2021) показали важливі протизапальні властивості застосування НЧ Золота мишам в якості ад'ювантного препарату поряд з антибіотиками при лікуванні сепсису [22]. У комбінованій формі НЧ Золота сприяють зменшенню проявів запалення за цукрового діабету та можуть використовуватися для профілактики ускладнень метаболічного синдрому [23]. Протизапальна активність, антимікробна дія і антиоксидантні властивості НЧ Срібла й Золота узагальнені у таблиці 1.…”